Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Maxwell

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Bioorganic & Medicinal Chemistry|June 21, 2024
Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM studyNace Zidar, Andrej Emanuel Cotman, Wessel Sinnige, et al.
Tuberculosis (Edinburgh, Scotland)|September 13, 2018
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymeraseGiorgia Mori, Beatrice Silvia Orena, Clara Franch, et al.
Journal of Medicinal Chemistry|January 12, 2023
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, et al.
Journal of Medicinal Chemistry|March 6, 2023
New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate <i>Staphylococcus aureus</i>Martina Durcik, Andrej Emanuel Cotman, Žan Toplak, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Bioorganic & Medicinal Chemistry|June 21, 2024
Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM studyNace Zidar, Andrej Emanuel Cotman, Wessel Sinnige, et al.
Tuberculosis (Edinburgh, Scotland)|September 13, 2018
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymeraseGiorgia Mori, Beatrice Silvia Orena, Clara Franch, et al.
Journal of Medicinal Chemistry|January 12, 2023
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, et al.
Journal of Medicinal Chemistry|March 6, 2023
New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate <i>Staphylococcus aureus</i>Martina Durcik, Andrej Emanuel Cotman, Žan Toplak, et al.
Pageof 15